We are live on ! Find out more
DARE icon

Dare Bioscience
DARE

36 hedge funds and large institutions have $3.35M invested in Dare Bioscience in 2024 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 8 increasing their positions, 8 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

64% more capital invested

Capital invested by funds: $2.04M → $3.35M (+$1.31M)

17% more first-time investments, than exits

New positions opened: 7 | Existing positions closed: 6

3% more funds holding

Funds holding: 35 → 36 (+1)

0.02% more ownership

Funds ownership: 0.56% → 0.58% (+0.02%)

0% more repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 8

Holders
36
Holders Change
+1
Holders Change %
+2.86%
% of All Funds
0.52%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
8
Reduced
8
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
+$65.8K
2
Renaissance Technologies
Renaissance Technologies
New York
+$17.8K
3
TSS
Two Sigma Securities
New York
+$13.6K
4
XT
XTX Topco
Cayman Islands
+$11.5K
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$10.7K

Top Sellers

Rank Fund Capital Flow
1
HighTower Advisors
HighTower Advisors
Illinois
-$14.7K
2
VH
Visionary Horizons
Tennessee
-$11.5K
3
ZIG
Zuckerman Investment Group
Illinois
-$7.13K
4
JP Morgan Chase
JP Morgan Chase
New York
-$4.92K
5
VF
Virtu Financial
New York
-$4K
Name Holding Trade Value Shares
Change 		Change in
Stake
FPF
26
First Pacific Financial
Washington
$4.9K – – –
PNC Financial Services Group
27
PNC Financial Services Group
Pennsylvania
$2.16K – – –
Fidelity Investments
28
Fidelity Investments
Massachusetts
$527 +$441 +90 New
Wells Fargo
29
Wells Fargo
California
$378 +$5 +1 +2%
UBS Group
30
UBS Group
Switzerland
$245 -$3.31K -675 -94%
JP Morgan Chase
31
JP Morgan Chase
New York
$117 -$4.92K -1,005 -98%
CSC
32
Caldwell Sutter Capital
California
$98 – – –
Bank of America
33
Bank of America
North Carolina
$72 -$54 -11 -48%
CPG
34
Cornerstone Planning Group
New Jersey
$5 – – –
NA
35
NewEdge Advisors
Louisiana
$5 – – –
VH
36
Visionary Horizons
Tennessee
– -$11.5K -3,104 Closed
ZIG
37
Zuckerman Investment Group
Illinois
– -$7.13K -1,922 Closed
VF
38
Virtu Financial
New York
– -$4K -1,172 Closed
LPP
39
Life Planning Partners
Florida
– -$119 -32 Closed
Morgan Stanley
40
Morgan Stanley
New York
– -$90 -24 Closed
CAL
41
Capital Advisors Ltd
Ohio
– +$83 +17 New
1
2

DARE Hedge Fund Activity: Q1 2024 in Review

36 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Dare Bioscience (DARE) for Q1 2024, worth a combined $3.35M — up 64% from $2.04M a quarter earlier.

Buyers outnumbered sellers: 7 funds opened new DARE positions and 6 closed out — a net gain of 1 holder — while 8 added to existing stakes and 8 trimmed.

The largest buyer was Citadel Advisors, opening a new position worth an estimated $65.8K. The largest seller was HighTower Advisors, cutting an estimated $14.7K.

  • 36 institutional investors held Dare Bioscience (DARE) as of Q1 2024, up from 35 in Q4 2023.
  • Funds reported $3.35M of Dare Bioscience stock for Q1 2024, up 64% quarter-over-quarter.
  • 7 funds opened new Dare Bioscience positions in Q1 2024 and 6 closed out, a net change of +1 holder.
  • The largest Dare Bioscience buyer in Q1 2024 was Citadel Advisors, an estimated $65.8K added.
  • The largest Dare Bioscience seller in Q1 2024 was HighTower Advisors, an estimated $14.7K sold.

Based on aggregated 13F filings for Q1 2024.